Nested Therapeutics, a clinical-stage oncology company developing transformative therapies for RAS/MAPK-driven disorders, today reported initial clinical results from its ongoing Phase 1 study ...

Positive real-world head-to-head data on GraftAssureTM assay to be presented at the 39th European Immunogenetics and Histocompatibility Conference (EFI2026), April 21--24, 2026 in Edinburgh, Scotland ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) ...

Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a ...

An international team led by Dr. Indrani Das of Academia Sinica Institute of Astronomy and Astrophysics (ASIAA) has shown, ...

Leucine-rich repeat-containing 8A (LRRC8A) is a ubiquitously expressed transmembrane protein that functions as the essential ...

The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will ...

A minority of patients requiring blood transfusions are increasingly requesting ‘unvaccinated’ blood in the United States, ...

Scientists have found the strongest evidence to date that a condition known as Barrett’s oesophagus is the starting point for all cases of oesophageal adenocarcinoma – the most common type of ...

The largest published prospective evaluation of off-label targeted cancer therapies has shown that more patients could ...